Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
- Resource Type
- Article
- Authors
- Herzog, Thomas J.; Pignata, Sandro; Ghamande, Sharad A.; Rubio, Maria-Jesús; Fujiwara, Keiichi; Vulsteke, Christof; Armstrong, Deborah K.; Sehouli, Jalid; Coleman, Robert L.; Gabra, Hani; Scambia, Giovanni; Monk, Bradley J.; Arranz, José A.; Ushijima, Kimio; Hanna, Rabbie; Zamagni, Claudio; Wenham, Robert M.; González-Martín, Antionio; Slomovitz, Brian; Jia, Yan; Ramsay, Lisa; Tewari, Krishnansu S.; Weil, Susan C.; Vergote, Ignace B.
- Source
- In Gynecologic Oncology March 2023 170:300-308
- Subject
- Language
- ISSN
- 0090-8258